Risperidone - Behavioural and Psychological Symptoms of Dementia
You are here : Home > Formulary Search > Risperidone - Behavioural and Psychological Symptoms of Dementia
Status 1
- Oral solution
- Tablets
Status 2
- Oro-dispersible tablets
Only for use where the liquid formulation is unsuitable e.g. for supervised administration to ensure compliance.
Documentation
PAD Profile
Licensed for up to 6 weeks in Alzheimer's dementia. On initiation, patients need a referal to SABP so that an assessment can be made at 6 weeks to weigh up response to treatment and benefit of treatment v risk of harm.
Other Indications
Below are listed other indications that Risperidone is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Behavioural and Psychological Symptoms of Dementia.
Committee Recommendations (2)
The Surrey Heartlands Integrated Care System Area Prescribing Committee agreed the updated resource pack for use by primary care prescribers for managing non-cognitive symptoms in people living with dementia.
Risperidone has been agreed as GREEN for agression, agitation or anxiety.
The Surrey & North West Sussex Area Prescribing Committee (APC) recommends risperidone for the treatment of moderate to severe Alzheimers dementia who have persistent aggression that is unresponsive to non-pharmacological approaches which must be tried as first line AND where there is a risk of harm to self or others.
Risperidone for this indication will be considered GREEN on the traffic light system for up to 6 weeks. The primary care prescriber should refer the patient to a specialist on initiation so that when the patient is seen by the specialist the response to risperidone can be reviewed.